IDH mutations were first discovered in rare GBMs of younger adults [81] and represent the most frequent alteration in LGGs, where they represent a principal mechanism of enhanced histone and DNA methylation referred to as the glioma CpG island methylator phenotype (g-CIMP) [63]. The gene discussed is IDH2; the disease is central nervous system cancer.